Dsc Advisors, L.P. Johnson & Johnson Transaction History

Dsc Advisors, L.P.

$28.6 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $232,153 - $258,329	-1,439 Reduced 31.52%	3,127 $511,000
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $29,769 - $32,923	-177 Reduced 3.73%	4,566 $811,000
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $403,731 - $458,493	2,553 Added 116.58%	4,743 $841,000
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $12,474 - $13,840	-80 Reduced 3.52%	2,190 $375,000
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $20,349 - $22,613	126 Added 5.88%	2,270 $367,000
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $104,459 - $112,050	-655 Reduced 23.4%	2,144 $353,000
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $428,442 - $477,173	2,799 New	2,799 $460,000
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $283,295 - $392,520	-2,549 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $37,357 - $42,906	293 Added 12.99%	2,549 $372,000
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $11,552 - $12,934	91 Added 4.2%	2,256 $292,000
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $20,328 - $22,357	155 Added 7.71%	2,165 $302,000
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $35,327 - $39,280	-281 Reduced 12.27%	2,010 $281,000
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $36,237 - $43,612	295 Added 14.78%	2,291 $296,000
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $37,081 - $43,578	305 Added 18.04%	1,996 $276,000
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $10,149 - $11,199	-85 Reduced 4.79%	1,691 $205,000
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $37,905 - $44,886	303 Added 20.57%	1,776 $228,000
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $131,088 - $143,476	-999 Reduced 40.41%	1,473 $206,000
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $320,049 - $334,659	2,472	2,472 $321,000

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dsc Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Dsc Advisors, L.P. with notifications on news.

Account